Related references
Note: Only part of the references are listed.Early-life fingolimod treatment improves intestinal homeostasis and pancreatic immune tolerance in non-obese diabetic mice
Ling-ling Jia et al.
ACTA PHARMACOLOGICA SINICA (2021)
Sphingosine 1-phosphate Receptor Modulator Therapy for Multiple Sclerosis: Differential Downstream Receptor Signalling and Clinical Profile Effects
Jerold Chun et al.
DRUGS (2021)
Sphingosine 1-Phosphate Receptor Modulators for Multiple Sclerosis
Reshmi Roy et al.
CNS DRUGS (2021)
Ponesimod: First Approval
Anthony Markham
DRUGS (2021)
Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis
Tamara Perez-Jeldres et al.
DRUGS (2021)
Ponesimod modulates the Th1/Th17/Treg cell balance and ameliorates disease in experimental autoimmune encephalomyelitis
Huiqing Hou et al.
JOURNAL OF NEUROIMMUNOLOGY (2021)
Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2TOUCHSTONE Study
William J. Sandborn et al.
JOURNAL OF CROHNS & COLITIS (2021)
Mechanism of action of s1p receptor modulators in multiple sclerosis: The double requirement
Regis Bordet et al.
REVUE NEUROLOGIQUE (2020)
The multiple sclerosis gut microbiota: A systematic review
Ali Mirza et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Siponimod (BAF312) Activates Nrf2 While Hampering NFκB in Human Astrocytes, and Protects From Astrocyte-Induced Neurodegeneration
Emanuela Colombo et al.
FRONTIERS IN IMMUNOLOGY (2020)
Central Modulation of Selective Sphingosine-1-Phosphate Receptor 1 Ameliorates Experimental Multiple Sclerosis
Alessandra Musella et al.
CELLS (2020)
Microbiome in Multiple Sclerosis: Where Are We, What We Know and Do Not Know
Marina Kleopatra Boziki et al.
BRAIN SCIENCES (2020)
Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study
Brian G. Feagan et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Siponimod therapy implicates Th17 cells in a preclinical model of subpial cortical injury
Lesley A. Ward et al.
JCI INSIGHT (2020)
Fingolimod modulates T cell phenotype and regulatory T cell plasticity in vivo
Margarita Dominguez-Villar et al.
JOURNAL OF AUTOIMMUNITY (2019)
Combination Therapy With Fingolimod and Neural Stem Cells Promotes Functional Myelination in vivo Through a Non-immunomodulatory Mechanism
Yuan Zhang et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Myeloid sphingosine-1-phosphate receptor 1 is important for CNS autoimmunity and neuroinflammation
Hsing-Chuan Tsai et al.
JOURNAL OF AUTOIMMUNITY (2019)
Progressive multiple sclerosis: from pathophysiology to therapeutic strategies
Simon Faissner et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
The next-generation sphingosine-1 receptor modulator BAF312 (siponimod) improves cortical network functionality in focal autoimmune encephalomyelitis
Petra Hundehege et al.
NEURAL REGENERATION RESEARCH (2019)
Sphingosine 1-phosphate and inflammation
Hideru Obinata et al.
INTERNATIONAL IMMUNOLOGY (2019)
The FLUENT study design: investigating immune cell subset and neurofilament changes in patients with relapsing multiple sclerosis treated with fingolimod
Jeffrey A. Cohen et al.
MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL (2019)
Two-year results from a phase 2 extension study of oral amiselimod in relapsing multiple sclerosis
Ludwig Kappos et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Ponesimod, a selective sphingosine 1-phosphate (S1P1) receptor modulator for autoimmune diseases: review of clinical pharmacokinetics and drug disposition
Ranjeet Prasad Dash et al.
XENOBIOTICA (2018)
Two-year results from a phase 2 extension study of oral amiselimod in relapsing multiple sclerosis
Ludwig Kappos et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
The intestinal barrier in multiple sclerosis: implications for pathophysiology and therapeutics
Carlos R. Camara-Lemarroy et al.
BRAIN (2018)
Sphingosine-1-phosphate receptors and innate immunity
Arielle M. Bryan et al.
CELLULAR MICROBIOLOGY (2018)
B cells in multiple sclerosis
Mireia Sospedra
CURRENT OPINION IN NEUROLOGY (2018)
LPS and palmitate synergistically stimulate sphingosine kinase 1 and increase sphingosine 1 phosphate in RAW264.7 macrophages
Junfei Jin et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2018)
Sphingosine 1-phosphate receptors regulate TLR4-induced CXCL5 release from astrocytes and microglia
Sinead A. O'Sullivan et al.
JOURNAL OF NEUROCHEMISTRY (2018)
Therapeutic Monoclonal Antibodies and Multiple Sclerosis: The Essentials
Ioannis Heliopoulos et al.
MEDICINAL CHEMISTRY (2018)
The Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor 2 Axis in Intestinal Epithelial Cells Regulates Intestinal Barrier Function During Intestinal Epithelial Cells-CD4+T-Cell Interactions
Tanzhou Chen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Regulatory role of sphingosine kinase and sphingosine-1-phosphate receptor signaling in progenitor/stem cells
Mei Li Ng et al.
WORLD JOURNAL OF STEM CELLS (2018)
A sphingosine 1-phosphate receptor agonist ameliorates animal model of vasculitis
Chie Miyabe et al.
INFLAMMATION RESEARCH (2017)
Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: A pilot study
Maria Chiara Buscarinu et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Altered intestinal permeability in patients with relapsing-remitting multiple sclerosis: A pilot study
Maria Chiara Buscarinu et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Sphingosine-1 phosphate promotes intestinal epithelial cell proliferation via S1PR2
Tanzhou Chen et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2017)
The Microbiome-Gut-Brain Axis in Health and Disease
Timothy G. Dinan et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2017)
Sphingosine-1-Phosphate Receptor 1, Expressed in Myeloid Cells, Slows Diet-Induced Atherosclerosis and Protects against Macrophage Apoptosis in Ldlr KO Mice
Leticia Gonzalez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Fingolimod additionally acts as immunomodulator focused on the innate immune system beyond its prominent effects on lymphocyte recirculation
Katja Thomas et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Implication of sphingosine-1-phosphate signaling in diseases: molecular mechanism and therapeutic strategies
Mohd Arish et al.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION (2017)
Beyond Immune Cell Migration: The Emerging Role of the Sphingosine-1-phosphate Receptor S1PR4 as a Modulator of Innate Immune Cell Activation
Catherine Olesch et al.
MEDIATORS OF INFLAMMATION (2017)
Effect of Fingolimod on Neural Stem Cells: A Novel Mechanism and Broadened Application for Neural Repair
Yuan Zhang et al.
MOLECULAR THERAPY (2017)
Sphingosine-1-phosphate receptor therapies: Advances in clinical trials for CNS-related diseases
Sinead O'Sullivan et al.
NEUROPHARMACOLOGY (2017)
Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation
Veit Rothhammer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Size-selective opening of the blood-brain barrier by targeting endothelial sphingosine 1-phosphate receptor 1
Keisuke Yanagida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models
Egle Cekanaviciute et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Mechanisms of Cell Polarity-Controlled Epithelial Homeostasis and Immunity in the Intestine
Leon J. Klunder et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2017)
Human Gut-Derived Commensal Bacteria Suppress CNS Inflammatory and Demyelinating Disease
Ashutosh Mangalam et al.
CELL REPORTS (2017)
Oral Multiple Sclerosis Drugs Inhibit the In vitro Growth of Epsilon Toxin Producing Gut Bacterium, Clostridium perfringens
Kareem R. Rumah et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
Oral Administration of the Probiotic Strain Escherichia coli Nissle 1917 Reduces Susceptibility to Neuroinflammation and Repairs Experimental Autoimmune Encephalomyelitis-Induced Intestinal Barrier Dysfunction
Thomas Secher et al.
FRONTIERS IN IMMUNOLOGY (2017)
Benefit-Risk Profile of Sphingosine-1-Phosphate Receptor Modulators in Relapsing and Secondary Progressive Multiple Sclerosis
Giancarlo Comi et al.
DRUGS (2017)
Multiple Sclerosis: Immunopathology and Treatment Update
Narges Dargahi et al.
BRAIN SCIENCES (2017)
Introduction to the human gut microbiota
Elizabeth Thursby et al.
BIOCHEMICAL JOURNAL (2017)
The sphingosine-1-phosphate receptor: A novel therapeutic target for multiple sclerosis and other autoimmune diseases
Yang Mao-Draayer et al.
CLINICAL IMMUNOLOGY (2017)
The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis
Samuel F. Hunter et al.
CNS DRUGS (2016)
Transcriptional modulation of SLC26A3 (DRA) by sphingosine-1-phosphate
Arivarasu N. Anbazhagan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)
Ozanimod (RPC1063) is a potent sphingosine-1-phosphate receptor-1 (S1P1) and receptor-5 (S1P5) agonist with autoimmune disease-modifying activity
F. L. Scott et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Sphingosine-1-Phosphate (S1P) and S1P Signaling Pathway: Therapeutic Targets in Autoimmunity and Inflammation
Hsing-Chuan Tsai et al.
DRUGS (2016)
Impaired endothelial barrier function in apolipoprotein M-deficient mice is dependent on sphingosine-1-phosphate receptor 1
Pernille M. Christensen et al.
FASEB JOURNAL (2016)
Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis
Shiri Blumenfeld et al.
JOURNAL OF AUTOIMMUNITY (2016)
Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis
Antonietta Gentile et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trial
Ludwig Kappos et al.
LANCET NEUROLOGY (2016)
Characterization of secreted sphingosine-1-phosphate lyases required for virulence and intracellular survival of Burkholderia pseudomallei
Rafael Custodio et al.
MOLECULAR MICROBIOLOGY (2016)
Sphingosine-1-Phosphate Receptor Antagonism Enhances Proliferation and Migration of Engrafted Neural Progenitor Cells in a Model of Viral-Induced Demyelination
Caroline A. Blanc et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Sphingosine 1-phosphate Receptor 2 Signaling Suppresses Macrophage Phagocytosis and Impairs Host Defense against Sepsis
JinChao Hou et al.
ANESTHESIOLOGY (2015)
S1PR4 is required for plasmacytoid dendritic cell differentiation
Christina Dillmann et al.
BIOLOGICAL CHEMISTRY (2015)
IL-17-Producing Vγ4+ γδ T Cells Require Sphingosine 1-Phosphate Receptor 1 for Their Egress from the Lymph Nodes under Homeostatic and Inflammatory Conditions
Yasuhiro Maeda et al.
JOURNAL OF IMMUNOLOGY (2015)
Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis
Jing Zhang et al.
NEUROBIOLOGY OF DISEASE (2015)
The intestinal barrier function and its involvement in digestive disease
Eloisa Salvo Romero et al.
REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS (2015)
HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation
Sylvain Galvani et al.
SCIENCE SIGNALING (2015)
Sphingosine 1-phosphate signaling at the blood-brain barrier
Briana Prager et al.
TRENDS IN MOLECULAR MEDICINE (2015)
Clostridium perfringens Epsilon Toxin Causes Selective Death of Mature Oligodendrocytes and Central Nervous System Demyelination
Jennifer R. Linden et al.
MBIO (2015)
The Myelin and Lymphocyte Protein MAL Is Required for Binding and Activity of Clostridium perfringens ε-Toxin
Kareem Rashid Rumah et al.
PLOS PATHOGENS (2015)
HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation
Sylvain Galvani et al.
SCIENCE SIGNALING (2015)
Myeloid cells as target of fingolimod action in multiple sclerosis
Marco Di Dario et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Immunopathology of multiple sclerosis
Calliope A. Dendrou et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Demyelination during multiple sclerosis is associated with combined activation of microglia/macrophages by IFN-γ and alpha B-crystallin
Malika Bsibsi et al.
ACTA NEUROPATHOLOGICA (2014)
Fingolimod May Support Neuroprotection via Blockade of Astrocyte Nitric Oxide
Emanuela Colombo et al.
ANNALS OF NEUROLOGY (2014)
The mechanism by which MEK/ERK regulates JNK and p38 activity in polyamine depleted IEC-6 cells during apoptosis
Mitul N. Bavaria et al.
APOPTOSIS (2014)
Intestinal Barrier Dysfunction Develops at the Onset of Experimental Autoimmune Encephalomyelitis, and Can Be Induced by Adoptive Transfer of Auto-Reactive T Cells
Mehrnaz Nouri et al.
PLOS ONE (2014)
Lysophospholipids and their receptors in the central nervous system
Ji Woong Choi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2013)
Efficacy and immunomodulatory actions of ONO-4641, a novel selective agonist for sphingosine 1-phosphate receptors 1 and 5, in preclinical models of multiple sclerosis
T. Komiya et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
S1PR5 is pivotal for the homeostasis of patrolling monocytes
Emilie Debien et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
Sphingosine-1-phosphate receptor 2
Mohamad Adada et al.
FEBS JOURNAL (2013)
Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy
Aran Groves et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Sphingosine 1-Phosphate Mediates Hyperalgesia via a Neutrophil-Dependent Mechanism
Amanda Finley et al.
PLOS ONE (2013)
Commensal Akkermansia muciniphila Exacerbates Gut Inflammation in Salmonella Typhimurium-Infected Gnotobiotic Mice
Bhanu Priya Ganesh et al.
PLOS ONE (2013)
Isolation of Clostridium perfringens Type B in an Individual at First Clinical Presentation of Multiple Sclerosis Provides Clues for Environmental Triggers of the Disease
Kareem Rashid Rumah et al.
PLOS ONE (2013)
Sphingosine-1-Phosphate and Lymphocyte Egress from Lymphoid Organs
Jason G. Cyster et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
Oral fingolimod rescues the functional deficits of synapses in experimental autoimmune encephalomyelitis
S. Rossi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Immunological Function of Sphingosine 1-Phosphate in the Intestine
Jun Kunisawa et al.
NUTRIENTS (2012)
The Transporter Spns2 Is Required for Secretion of Lymph but Not Plasma Sphingosine-1-Phosphate
Alejandra Mendoza et al.
CELL REPORTS (2012)
Inflammation, demyelination, and degeneration - Recent insights from MS pathology
Christine Stadelmann et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Sphingosine-1-Phosphate Receptor 3 Promotes Recruitment of Monocyte/Macrophages in Inflammation and Atherosclerosis
Petra Keul et al.
CIRCULATION RESEARCH (2011)
Sphingosine-1-Phosphate Regulates the Expression of Adherens Junction Protein E-Cadherin and Enhances Intestinal Epithelial Cell Barrier Function
Jose Greenspon et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Neurobiological effects of sphingosine 1-phosphate receptor modulation in the cuprizone model
Hye Jung Kim et al.
FASEB JOURNAL (2011)
Sphingomyelin induces cathepsin D-mediated apoptosis in intestinal epithelial cells and increases inflammation in DSS colitis
Anne Fischbeck et al.
GUT (2011)
Sphingosine-1-phosphate Lyase Deficiency Produces a Pro-inflammatory Response While Impairing Neutrophil Trafficking
Maria L. Allende et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Suppression of intestinal inflammation and inflammation-driven colon cancer in mice by dietary sphingomyelin: importance of peroxisome proliferator-activated receptor γ expression
Joseph C. Mazzei et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2011)
There is More to a Lipid than just Being a Fat: Sphingolipid-Guided Differentiation of Oligodendroglial Lineage from Embryonic Stem Cells
Erhard Bieberich
NEUROCHEMICAL RESEARCH (2011)
Sphingosine 1-phosphate (S1P) Physiology and the effects of S1P receptor modulation
Timothy Hla et al.
NEUROLOGY (2011)
The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators
Betty Soliven et al.
NEUROLOGY (2011)
Role of sphingosine-1-phosphate (S1P) and S1P receptor 2 in the phagocytosis of Cryptococcus neoformans by alveolar macrophages
Travis McQuiston et al.
MICROBIOLOGY-SGM (2011)
Sphingosine Kinase 1 and Sphingosine 1-Phosphate Receptor 3 Are Functionally Upregulated on Astrocytes under Pro-Inflammatory Conditions
Iris Fischer et al.
PLOS ONE (2011)
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
Ji Woong Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Fingolimod (FTY720): First approved oral therapy for multiple sclerosis
Sushil Sharma et al.
JOURNAL OF PHARMACOLOGY & PHARMACOTHERAPEUTICS (2011)
Plasma membrane sphingomyelin hydrolysis increases hippocampal neuron excitability by sphingosine-1-phosphate mediated mechanisms
Eric Norman et al.
JOURNAL OF NEUROCHEMISTRY (2010)
A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease
J. Ochoa-Reparaz et al.
MUCOSAL IMMUNOLOGY (2010)
The S1P1-mTOR axis directs the reciprocal differentiation of TH1 and Treg cells
Guangwei Liu et al.
NATURE IMMUNOLOGY (2010)
REGULATION OF SYNAPTIC STRENGTH BY SPHINGOSINE 1-PHOSPHATE IN THE HIPPOCAMPUS
T. Kanno et al.
NEUROSCIENCE (2010)
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sphingosine 1-Phosphate Receptor Signaling
Hugh Rosen et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2009)
Sphingosine-1-Phosphate Protects Intestinal Epithelial Cells from Apoptosis Through the Akt Signaling Pathway
Jose Greenspon et al.
DIGESTIVE DISEASES AND SCIENCES (2009)
Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice
Eric Camerer et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow
Craig N. Jenne et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Chemical modulators of sphingosine-1-phosphate receptors as barrier-oriented therapeutic molecules
David Marsolais et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
FTY720 modulates human oligodendrocyte progenitor process extension and survival
Veronique E. Miron et al.
ANNALS OF NEUROLOGY (2008)
Vascular endothelium as a contributor of plasma sphingosine 1-phosphate
Krishnan Venkataraman et al.
CIRCULATION RESEARCH (2008)
Sphingosine kinase 1/S1P receptor signaling axis controls glial proliferation in mice with Sandhoff disease
Yun-Ping Wu et al.
HUMAN MOLECULAR GENETICS (2008)
Central nervous system-directed effects of FTY720 (fingolimod)
Veronique E. Miron et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Suppression of ulcerative colitis in mice by orally available inhibitors of sphingosine kinase
Lynn W. Maines et al.
DIGESTIVE DISEASES AND SCIENCES (2008)
Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor
Thierry Walzer et al.
NATURE IMMUNOLOGY (2007)
Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells
C. G. Jung et al.
GLIA (2007)
Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues
Steffen Massberg et al.
CELL (2007)
Activation of sphingosine-1-phosphate receptor S1P5 inhibits oligodendrocyte progenitor migration
Alexander S. Novgorodov et al.
FASEB JOURNAL (2007)
Sphingosine 1-phosphate regulates peritoneal B-cell trafficking for subsequent intestinal IgA production
Jun Kunisawa et al.
BLOOD (2007)
Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors
Maribel Osinde et al.
NEUROPHARMACOLOGY (2007)
Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720
Y Kharel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients
SR Schwab et al.
SCIENCE (2005)
Edg8/S1P5: An oligodendroglial receptor with dual function on process retraction and cell survival
C Jaillard et al.
JOURNAL OF NEUROSCIENCE (2005)
Sphingosine-1-phosphate mediates migration of mature dendritic cells
N Czeloth et al.
JOURNAL OF IMMUNOLOGY (2005)
Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
M Matloubian et al.
NATURE (2004)
Differential transactivation of sphingosine-1-phosphate receptors modulates NGF-induced neurite extension
RE Toman et al.
JOURNAL OF CELL BIOLOGY (2004)
Growth factor pre-treatment differentially regulates phosphoinositide turnover downstream of lysophospholipid receptor and metabotropic glutamate receptors in cultured rat cerebrocortical astrocytes
TS Rao et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2004)
Characterization of lysophosphatidic acid and sphingosine-1-phosphate-mediated signal transduction in rat cortical oligodendrocytes
NC Yu et al.
GLIA (2004)
Microglial activation state and lysophospholipid acid receptor expression
CS Tham et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2003)
Marked perinatal lethality and cellular signaling deficits in mice null for the two sphingosine 1-phosphate (S1P) receptors, S1P2/LPB2/EDG-5 and S1P3/LPB3/EDG-3
I Ishii et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement
JGN Garcia et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
An essential role for the H218/AGR16/Edg-5/LPB2 sphingosine 1-phosphate receptor in neuronal excitability
AJ MacLennan et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2001)
A mutual inhibitory effect on absorption of sphingomyelin and cholesterol
L Nyberg et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2000)
Share Paper
